The C-suite sells are noise—small dollar amounts likely tied to tax withholding or 10b5-1 plans. The real signal is Baker Brothers' $33M open-market purchase at the offering price, which is a massive vote of confidence. This offsets the bearish dilution narrative from the $150M offering. Traders should watch for additional insider buying from Baker or other directors in the coming days. The stock may find support near the $12.06 offering price given Baker's floor.
Price Chart
Executive Summary
Replimune insiders (CEO, CFO, CMO, CAO) sold $906K in open-market sales on August 10, 2026, the same day as a $150M dilutive offering priced at $12.06. The sales are small relative to the $1.1B market cap (0.08%), but the timing—coinciding with the offering—suggests insiders were selling into the offering price. Critically, Baker Brothers, a director and the company's largest holder, purchased $33M in open-market shares on August 11, 2026, at the offering price, signaling confidence in the post-dilution value. The cluster is mixed: C-suite sells are routine liquidity (likely 10b5-1 or tax-related), while Baker's massive buy is a strong bullish signal that partially offsets the dilution narrative.
Key Financial Metrics
Key Facts
- CEO Sushil Patel sold 39,341 shares for $510K on 2026-08-10
- CFO Emily Hill sold 11,448 shares for $148K on 2026-08-10
- CMO Konstantinos Xynos sold 11,447 shares for $148K on 2026-08-10
- CAO Andrew Schwendenman sold 7,632 shares for $99K on 2026-08-10
- Baker Brothers (Director) purchased 2,736,340 shares for $33M on 2026-08-11
- Total insider sales of $906K represent 0.08% of $1.1B market cap
- Baker Brothers' $33M purchase is 3.0% of market cap
- The $150M offering closed on 2026-08-10 at $12.06 per share
Financial Impact
Insider sales of $906K (0.08% of market cap) are trivial; Baker Brothers' $33M purchase (3.0% of market cap) is highly material and signals strong insider conviction
Risk Factors
- The $150M offering dilutes existing shareholders by ~13%, which could weigh on the stock near term
- Baker Brothers' purchase is a single event; if they sell in the future, it would be a negative signal
- The company has no product revenue and requires confirmatory trials for TUDRIQEV's accelerated approval
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-REPL-1786612060363 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 5w ago | Press Release | $14.71 $13.07 | ▲ +11.15% | ▲ +11.16% | $13.04 (+11.35%) |
Aug 19, 2026 6w ago | Insider Cluster | $14.05 $13.07 | ▼ −6.98% | ▼ −6.98% | $13.04 (−7.19%) |
Aug 14, 2026 7w ago | 8-K | $14.97 $13.11 | ▼ −12.42% | ▼ −10.43% | $13.04 (−12.89%) |
Aug 14, 2026 7w ago | Press Release | $14.97 $13.11 | ▼ −12.42% | ▼ −10.43% | $13.04 (−12.89%) |
Aug 12, 2026 7w ago | Insider Cluster | $15.19 $12.92 | ▼ −14.94% | ▼ −13.20% | $13.04 (−14.15%) |
Aug 12, 2026 7w ago | Insider Cluster | $15.19 $12.92 | ▼ −14.94% | ▼ −13.20% | $13.04 (−14.15%) |
Aug 10, 2026 7w ago | Press Release | $13.67 $14.77 | ▼ −8.05% | ▼ −8.96% | $13.04 (+4.61%) |
Aug 10, 2026 7w ago | 8-K | $13.67 $14.77 | ▼ −8.05% | ▼ −8.96% | $13.04 (+4.61%) |
Aug 10, 2026 7w ago | 424B5 | $13.67 $14.77 | ▼ −8.05% | ▼ −8.96% | $13.04 (+4.61%) |
Aug 7, 2026 8w ago | 8-K | $12.06 $15.04 | ▲ +24.71% | ▲ +25.11% | $13.04 (+8.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access